Alexion Pharmaceuticals plans to invest $10 million in labs at its facility in the city to increase the company’s capacity to reach clinical studies of its rare disease research. Alexion, in a statement, said its Global Product Development lab expansion at the 100 College St. site will be completed by the end of 2020. Yale University also announced in January that it would be leasing about half of the building for its science and engineering needs. He said it dovetails with expansion of the Downtown Corridor now underway that will open space for another research building similar to Alexion’s $100 million headquarters, which was the first in the corridor.
https://www.ctinsider.com/business/nhregister/article/Alexion-to-put-10-million-into-New-Haven-facility-14449798.php?_ga=2.252644303.752894330.1568889466-1283492455.1546819691